Skip to main content
PMC home page
PLOS Pathogens logoLink to PLOS Pathogens
. 2010 Oct 7;6(10):e1001143. doi: 10.1371/journal.ppat.1001143

Wolbachia Stimulates Immune Gene Expression and Inhibits Plasmodium Development in Anopheles gambiae

Zakaria Kambris 1, Andrew M Blagborough 2, Sofia B Pinto 1, Marcus S C Blagrove 1, H Charles J Godfray 1, Robert E Sinden 2, Steven P Sinkins 1,*
Editor: Kenneth D Vernick3
PMCID: PMC2951381  PMID: 20949079

Abstract

The over-replicating wMelPop strain of the endosymbiont Wolbachia pipientis has recently been shown to be capable of inducing immune upregulation and inhibition of pathogen transmission in Aedes aegypti mosquitoes. In order to examine whether comparable effects would be seen in the malaria vector Anopheles gambiae, transient somatic infections of wMelPop were created by intrathoracic inoculation. Upregulation of six selected immune genes was observed compared to controls, at least two of which (LRIM1 and TEP1) influence the development of malaria parasites. A stably infected An. gambiae cell line also showed increased expression of malaria-related immune genes. Highly significant reductions in Plasmodium infection intensity were observed in the wMelPop-infected cohort, and using gene knockdown, evidence for the role of TEP1 in this phenotype was obtained. Comparing the levels of upregulation in somatic and stably inherited wMelPop infections in Ae. aegypti revealed that levels of upregulation were lower in the somatic infections than in the stably transinfected line; inhibition of development of Brugia filarial nematodes was nevertheless observed in the somatic wMelPop infected females. Thus we consider that the effects observed in An. gambiae are also likely to be more pronounced if stably inherited wMelPop transinfections can be created, and that somatic infections of Wolbachia provide a useful model for examining effects on pathogen development or dissemination. The data are discussed with respect to the comparative effects on malaria vectorial capacity of life shortening and direct inhibition of Plasmodium development that can be produced by Wolbachia.

Author Summary

Malaria is one of the world's most devastating diseases, particularly in Africa, and new control strategies are desperately needed. Here we show that the presence of Wolbachia bacteria inhibits the development of a malaria parasite in the most important Anopheles mosquito species of Africa. In addition we show that the presence of Wolbachia results in the switching on of immune genes that are known to affect development of many species of malaria parasite. When added to the lifespan-shortening effects of this particular strain of Wolbachia, and the general ability of Wolbachia to spread through insect populations, our study provides a stimulus for the development of Wolbachia-based malaria control methods. It also provides new insights into the wide range of effects of Wolbachia in insects.

Introduction

Wolbachia pipientis is an intracellular maternally inherited bacterial symbiont of invertebrates that is very common in insects, including a number of mosquito species [1], [2]. It can manipulate host reproduction in several ways, including cytoplasmic incompatibility (CI), whereby certain crosses are rendered effectively sterile. Females that are uninfected produce infertile eggs when they mate with males that carry Wolbachia, while there is a ‘rescue’ effect in Wolbachia-infected embryos such that infected females can reproduce successfully with any males. Therefore uninfected females suffer a frequency-dependent reproductive disadvantage. Wolbachia is able to rapidly invade populations using this powerful mechanism [3]–[5].

A strain of Wolbachia called wMelPop has been identified that over-replicates in somatic tissues and roughly halves the lifespan of laboratory Drosophila melanogaster [6]. A transinfection of wMelPop from Drosophila into the mosquito Aedes aegypti also leads to a similarly shortened lifespan in the lab, as well as inducing strong CI, which has made it a very promising candidate for the development of new strategies for controlling mosquito-borne diseases [7]. All mosquito-borne pathogens require an extrinsic incubation period before they can be transmitted that is relatively long (∼9 days for malaria) compared to mean mosquito lifespan in the field; therefore, a reduction in the number of old individuals in the population will reduce disease transmission [8]–[11].

We recently found that the presence of wMelPop also produces a major upregulation of a large number of immune genes in Ae. aegypti and inhibits the development of filarial nematode worm parasites [12]. We hypothesized that the two effects are functionally related – higher levels of immune effectors in wMelPop-infected mosquitoes render them better able to kill parasites [12]. Homologs of some of the Ae. aegypti genes that are upregulated in the presence of wMelPop have been previously shown to have the ability to regulate development of Plasmodium parasites in Anopheles, for example a transgene encoding cecropin-A/a synthetic cecropin-B of Hyalophora cecropia; the NF-κB-like transcription factor Rel2 controlling the Imd pathway; and TEP (Thioester containing) opsonization proteins [13]–[20]. It has recently been shown that the wMelPop-infected Ae. aegypti line has impaired ability to transmit an avian malaria, Plasmodium gallinaceum [21]. It is possible that these effects of wMelPop could be particular to the Ae. aegypti transinfection; however, if comparable upregulation of orthologous immune genes, and inhibition of Plasmodium development are also seen in the important Anopheles vectors of human malaria, it may provide a stimulus to the development of new Wolbachia-based malaria control strategies.

To address this question we used Anopheles gambiae, the most important vector of malaria in Africa, which like Ae. aegypti is not naturally infected with Wolbachia. The creation of stably inherited lines of An. gambiae is likely to require a long period of microinjection and selection, as had to be performed for Ae. aegypti [7]. However, in advance of the successful creation of an An. gambiae stable transinfection, the effects of the presence of wMelPop on immunity and malaria transmission can be tested using an established wMelPop-infected An. gambiae cell line [22] and the ability to create somatic lifetime infections of Wolbachia in adult female mosquitoes by intrathoracic inoculation [23], [24]. The wMelPop strain forms disseminated somatic infections in its natural Drosophila host [6], in common with some but not all Wolbachia strains [25]. Given that a) Plasmodium parasites will travel solely through somatic tissues on their journey to the salivary glands, and b) that many of the known antimalarial immune effectors are humoral/systemic, we consider that the creation of somatic infections of Wolbachia via adult inoculation represents a useful model for stably inherited germline-associated infections. To examine this hypothesis further, we also created somatic wMelPop infections in Ae. aegypti, in order to compare the magnitude of the effects on mosquito immunity and filarial nematode parasite development with those observed in the stably wMelPop-transinfected line.

Results

Immune gene expression in An. gambiae

Given that a stable wMelPop infection of An. gambiae does not yet exist, it was necessary to create transient somatic infections by intrathoracic innoculation with purified Wolbachia. RNA from these transinfected females was then tested for expression levels of six immune genes, and upregulation of all these genes was observed compared to buffer injected and E. coli - injected controls (Figure 1). Of these genes, LRIM1 and TEP1 (whose products have been shown to interact in the opsonisation response) have previously been shown to have an important inhibitory or antagonistic effect on Plasmodium development [18]–[20]. Importantly, injected mosquitoes were left for eight days before Plasmodium challenge or qRT-PCR, and therefore the pulse of immune gene upregulation caused by the injury itself or by the E. coli challenge would be expected to have already passed [15].

Figure 1. Immune gene expression in An. gambiae somatically infected with wMelPop.

Figure 1

Open in a new tab

The expression of six immune genes were analyzed by qRT-PCR: leucine-rich repeat immune protein, LRIM1; thioester-containing protein, TEP1; cecropin, CEC1; defensin, DEF1; C-type lectin, CTL4; and clip-domain serine protease, CLIPB3. Adult An. gambiae females were injected with E. coli, wMelPop or the buffer alone, 2–3 days post-eclosion, and RNA was extracted from these adults eight days after injection. Expression was normalized to non-injected adult females of the same age from the same colony. Error bars show the SEM of three biological replicates, each containing eight adult females (total of 24 mosquitoes per condition).

The wMelPop infected cell line MOS55 [22] showed upregulation of all six selected immune genes compared to an uninfected cell line created by tetracycline curing of infected MOS55 (Figure 2). These data add confidence to the hypothesis that it is the presence of wMelPop itself that is inducing immune gene upregulation, and by extension Plasmodium inhibition, and that these effects are not artefacts of the intrathoracic injection process. The degree of upregulation was different for some genes in the cell line than observed for the somatic in vivo transinfection. However these differences would be expected given that many immune genes are primarily expressed in particular cell types/organs in adult mosquitoes, such as the fat body cells or in the case of TEP1, the haemocytes [18], and the cellular composition of this larval-derived cell line is unknown.

Figure 2. Immune gene expression in the An. gambiae wMelPop-infected MOS55 cell line.

Figure 2

Open in a new tab

The expression of six immune genes as described for Figure 1 were analyzed by qRT-PCR, for the An. gambiae MOS55 cell culture infected with wMelPop, normalized to expression of these genes in a tetracycline treated, wMelPop free, genetically identical, MOS55 cell culture. Three samples of cells were taken from the cultures at different times; error bars show the SEM of these three samples.

Effects on the development of Plasmodium berghei

Three Plasmodium berghei challenge experiments were conducted on transiently Wolbachia-infected A. gambiae females compared to buffer injected, uninjected, and in one case E. coli-injected controls (Figure 3a–c). In all three experiments highly significant reductions in intensity of oocyst infection in the wMelPop transinfected females were observed compared to the other treatments, while there were no significant differences between any of the control treatments within each experiment. Mean P. berghei intensities were reduced in the wMelPop-infected mosquitoes by between 75% and 84% compared to the corresponding buffer injected control groups. A further experiment confirmed the lack of any significant differences in intensity between the E. coli-injected, buffer injected and uninjected controls (data not shown).

Figure 3. An. gambiae somatically infected with wMelPop: challenges with Plasmodium berghei.

Figure 3

Open in a new tab

Each panel represents an independent experiment showing mean numbers of oocysts per midgut (parasite intensities), comparing An. gambiae challenged with P. berghei eight (A–C) or five (D) days after intrathoracic innoculation with, in A–C, Wolbachia wMelPop compared to buffer (BI) and non-injected (NI) controls plus in C E. coli (EI); and in (D) Wolbachia+dsLacZ (WLI), Wolbachia+dsTEP1 (WTI) and NI. Parasite survival was determined by oocyst counting on day 10 post infection. In A–C significant reductions in intensity were observed in WI females compared to the NI, BI and EI controls: ***P<0.001; ** P<0.01. P. berghei prevalence was also significantly reduced (P<0.05) in WI compared to one or more of the controls: expt. A. NI = 78.5% (33/42); BI = 81.8% (27/33), WI = 60.0% (27/45); expt. B NI = 88.4% (23/26), BI = 92.3% (12/13), WI = 57.1% (12/21; expt. C NI = 90.3% (28/31), BI = 96.0% (24/25), WI = 63.1% (12/19), EI = 81.2% (13/16). In experiment D intensity was significantly lower in the WLI group compared to WTI and NI, *P<0.05. Prevalence was 81% (39/48) for NI, 81% (13/16) for WTI and 50% (6/12) for WLI.

In order to obtain evidence for a causal link between the immune upregulation and the Plasmodium inhibition phenotypes, TEP1 knockdown was undertaken by injection of dsRNA at the same time as Wolbachia injection. Significantly higher oocyst numbers were observed compared to the control where dsLacZ was injected at the same time as Wolbachia (Figure 3d). This experiment provides evidence for a significant contribution of Wolbachia-induced TEP1 upregulation to the Plasmodium inhibition phenotype.

Utility of transient somatic wMelPop infections

We assessed the utility of the transient wMelPop somatic infection model by comparing the effects on host immunity and pathogen development with those observed in stable inherited infections of wMelPop. To do this we utilized a filarial nematode-susceptible line of another mosquito species, Ae. aegypti, in which we have previously carried out Brugia pahangi challenges on a stable wMelPop-transinfected line [7], [12]. We created somatic wMelPop infections using exactly the same methodology as carried out for An. gambiae, and after eight days challenged them with B. pahangi or carried out qRT-PCR.

The somatic Wolbachia infection also induced upregulation of selected immune genes (PGRPS1, CECD, CLIPB37, CTL) (Figure 4a). The scale of upregulation was considerably lower than observed in the comparable Ae. aegypti stable transinfection as previously reported [12]. Likewise, challenge of the somatically wMelPop infected females with B. pahangi did produce a significant reduction in the numbers developing to the L3 (infectious) stage compared to the controls (Figure 4b), as was previously observed in the stable inherited wMelPop infected line, which showed >50% reduction in mean numbers of L3 compared to the Wolbachia-uninfected control at the same microfilarial challenge density [12]. Using quantitative PCR comparing three groups of two mosquitoes with the single copy genes ftsZ (Wolbachia) and Actin5C (Ae. aegypti) for normalization, we estimated that there were approximately 176±70 times more wMelPop cells in the stably infected line compared to the somatic infections. This may explain this reduced effect on gene upregulation. Therefore we conclude that intrathoracic inoculation can be a valuable way to test the effects of Wolbachia on host immunity and pathogen transmission. Although extrapolations to different mosquito species and parasites must be made with care, it does seem likely that the effects observed for somatic Wolbachia infections using the methodology reported here are likely to be smaller than for a stable inherited infection, and thus that the estimations made may be conservative.

Figure 4. Immune gene expression and challenges with Brugia pahangi in Ae. aegypti somatically infected with wMelPop, and effects of immune knockdown on Wolbachia density.

Figure 4

Open in a new tab

A) The expression of four immune genes were analyzed by qRT-PCR: a peptidoglycan recognition protein, PGRPS1; cecropin D, CECD; CLIP-domain serine protease, CLIPB37; and a C-type galactose-specific lectin. Adult females were injected with wMelPop or the buffer alone, approximately seven days post-eclosion. RNA was extracted from these adults eight days after injection. Expression was normalized to non-injected adult females of the same age from the same colony. Error bars show the SEM of three biological replicates, each containing eight adult females (total of 24 mosquitoes per condition). B) The mean numbers of L3 stage (infective) larvae per mosquito are shown following B. pahangi challenge in Ae. aegypti Refm strain previously injected with wMelPop or buffer; * P<0.05. Numbers above bars show the prevalence of filarial infection as a proportion of mosquitoes that contained at least one L3 Brugia larva over the total number of mosquitoes dissected in each category. C) We measured the levels Wolbachia ftsZ gene expression as a proxy for Wolbachia density and normalized the qRT-PCR data to the mosquito Actin5C gene. Two sets of three females per time point injected with either dsLacZ or dsRel2 were assayed. ftsZ gene expression was found to be higher in dsRel2-injected mosquitoes than in dsLacZ-injected mosquitoes at both six and ten days post injection. The mean level of Rel2 transcript in dsRel2-injected mosquitoes was confirmed to be approximately 40% of that in dsLacZ injected mosquitoes at both time points. These data suggest that the immune effectors controlled by the Imd pathway (Rel2-controlled) can influence Wolbachia densities.

An experiment to test whether the immune upregulation observed in wMelPop-infected mosquitoes affects the density of the Wolbachia itself was conducted using the stable inherited infection of wMelPop in an Ae. aegypti Refm background [7], [12]. Wolbachia ftsZ gene expression (used as a proxy for Wolbachia density) was found to be higher in dsRel2-injected than in dsLacZ-injected mosquitoes at both day six and day ten post-injection (Figure 4c). These data suggest that the immune effectors controlled by the Imd (Rel2-controlled) pathway can influence Wolbachia densities. The very high rate of maternal transmission observed in wMelPop-infected Ae. aegypti [7], despite chronic immune upregulation, means that the biological significance of this density difference is unknown, although potentially it could act to limit wMelPop pathogenicity to some degree. More comprehensive experiments addressing this question will make use of transgenic immune knockdown lines infected with wMelPop, which are currently being produced, and are expected to enable the effects of stronger and more long lasting immune pathway knockdown to be investigated.

Discussion

The data reported strongly support the hypothesis that wMelPop can inhibit the development of Plasmodium in Anopheles malaria vector mosquitoes. The An. gambiae/P. berghei combination, although not one that occurs in nature, does represent a tractable and well studied model for which considerable information is already available about Plasmodium killing mechanisms; however we recognize the challenge experiments will ultimately need to be repeated with the far less tractable human parasite P. falciparum once a stably inherited Wolbachia transinfected line of An. gambiae has been created. The densities of P. berghei used in laboratory challenges such as these can be high compared to those of P. falciparum that would occur in nature, although the mean intensities recorded in these studies lie within the range recorded for P. falciparum in the field. The significant reductions in intensity we recorded in laboratory experiments are considered likely to translate to significant reductions in oocyst prevalence/transmission in a real-life setting.

The knockdown experiment provided evidence for a major role of TEP1, and by extension LRIM1 whose products interact as part of the same opsonization pathway [20], in the inhibition of P. berghei development. This is the first time a direct link between the Wolbachia pathogen inhibition and immune upregulation phenotypes has been made. A more detailed and exhaustive investigation of the relative contributions of different components of the Anopheles immune system to Plasmodium killing can be made once stable inherited Wolbachia infections have been established.

Taken together with the recent report of reduction in P. gallinaceum development in wMelPop-infected Ae. aegypti [21], the data increase the desirability of creating stably inherited wMelPop transinfections in important malaria vectors. The potential combination of lifespan shortening and direct inhibition of Plasmodium development in the mosquito would represent a very attractive control strategy, since both of these phenotypes are critical components of malaria vectorial capacity. A simple model exploring relative contributions of these two parameters to vectorial capacity is shown in Figure 5. Though lifespan reduction and Plasmodium inhibition can each substantially reduce the vectorial capacity of a mosquito population, together they act synergistically to reduce transmission. Depending on the scale of lifespan reduction that would be observed under field conditions, which is as yet unknown, the Plasmodium inhibition effect could dramatically increase the efficacy of the wMelPop infection in reducing malaria transmission.

Figure 5. Model of possible effects of wMelPop on malaria vectorial capacity.

Figure 5

Open in a new tab

Vectorial capacity is a measure that describes the transmission potential of a mosquito population and is independent of Plasmodium prevalence. It can be thought of as proportional to the number of infectious bites that occur per day after a single infectious human arrives in a previously malaria-free area. If we assume recruitment to the adult mosquito stage is constant then vectorial capacity can be written (A b (1−μ)τ)/μ where b is the ability of the mosquito to transmit Plasmodium, μ is adult daily survival, τ is the length of the intrinsic incubation period of the Plasmodium and all other parameters are combined in A [42]. The figure plots vectorial capacity as transmission (b) and daily survival (μ) are each reduced because of the presence of Wolbachia by a multiplicative factor (1−x) where x varies in the range 0 to 1 (parameters: b = 1; μ = 0.1; τ = 1; A = 1). A more advanced analysis tailored to a specific system might want to include age-specific adult mortality, the effect of Wolbachia on mosquito population dynamics and seasonality.

Other Wolbachia strains might also show malaria inhibition effects, particularly if they reach high somatic densities and/or induce large-scale immune stimulation. Here we show that the use of transient somatic infections of Wolbachia by adult female inoculation followed by pathogen challenge is a valuable means to test likely effects on immunity and transmission. This is significant as it allows comparison and selection of strains for the most desirable properties prior to the lengthy, and technically very challenging, process of creating stably inherited Anopheles transinfections. If other Wolbachia strains can be identified which also inhibit Plasmodium transmission, they would represent an attractive alternative to wMelPop if they do not shorten lifespan to the same extent, since they are therefore likely to have much lower fitness costs. Only the wMelPop strain has to date been found to produce a strong life-shortening phenotype.

Laboratory estimates suggest that transinfection of wMelPop in Aedes aegypti can reduce fitness by around 50% [7]. This would appear to make it difficult for this strain of Wolbachia to spread by means of CI through natural populations [26], particularly where populations are fragmented. However, fitness estimates made in relatively benign laboratory conditions, where a comparatively large fraction of the population become old, can overestimate the relative costs of infection. In the field most mosquitoes die early and few live long enough to experience higher Wolbachia-induced mortality (although those that do are significant to disease control, if they would otherwise have lived long enough to transmit the infection). As shown in Figure 5 reductions in longevity and Plasmodium inhibition together determine vectorial capacity and it will also be important to understand the joint effects of the two phenotypes on mosquito fitness in the field. Detailed knowledge of the demographics of the target species is also important [27]. Selective pressures acting on the host would likely modulate the life-shortening phenotype over time, but this may not occur rapidly enough to prevent a sustained period of disease control.

Wolbachia is now known to inhibit the dissemination or development of a variety of insect pathogens and insect-borne pathogens – various Drosophila pathogenic viruses, dengue and chikungunya viruses of humans, and filarial nematode parasites in addition to Plasmodium [12], [21], [28]–[31]. Some of these pathogen-inhibition phenotypes have been reported in Drosophila species that naturally harbour Wolbachia, in other words they are not restricted to species such as Ae. aegypti or An. gambiae in which Wolbachia forms a novel transinfection. On a broader level these Wolbachia cases can be added to various other examples where bacterial symbionts have been shown to provide protective effects against one or more pathogens [32], [33], although the mechanisms involved are likely to be diverse. Parallels can also be drawn with the effects of entomopathogenic fungi, which can both reduce Anopheles lifespan and directly inhibit Plasmodium development [34]–[36]. Pathogen inhibition represents a new and increasingly significant component of our understanding of the effects of Wolbachia in insects, and provides excellent prospects for the development of novel malaria control strategies.

Materials and Methods

Ethics statement

All procedures involving animals were approved by the ethical review committee of Imperial College and by the United Kingdom Government (Home Office), and were performed in accordance with United Kingdom Government (Home Office) and EC regulations.

Somatic wMelPop infections

Wolbachia wMelPop was purified from the infected An. gambiae cell line MOS55 [22], [37] as previously described [23], [24]. This protocol has previously been shown to allow Wolbachia replication in the recipient An. gambiae [24]. Cells obtained from one 75 CM2 flask were re-suspended in 100 µL of Schneider medium without antibiotics (optical density, OD = 0.09). 69 nL of this Wolbachia suspension (or 69 nL Schneider for the controls) were microinjected into the thorax of young An. gambiae females of the G3 strain or Ae. aegypti females of the Refm strain [38] using an Nanoject microinjector (Drummond). The mosquitoes were supplied with 10% sucrose ad libitum and left to recover for at least eight days prior to qRT-PCR or challenge experiments. A similar OD of 0.1 for E. coli was used to inject another set of controls.

qRT-PCR and qPCR

Gene expression levels were monitored using qRT-PCR. Total RNA was extracted with Trizol reagent from groups of ten An. gambiae or Ae. aegypti females maintained at 26°C and 70% relative humidity, and cDNAs were synthesised from 1 µg of total RNA using SuperScript II enzyme (Invitrogen). qRT-PCR was performed on a 1 to 20 dilution of the cDNAs using dsDNA dye SYBR Green I. Reactions were run on a DNA Engine thermocycler (MJ Research) with Chromo4 real-time PCR detection system (Bio-Rad) using the following cycling conditions: 95°C for 15 minutes, then 45 cycles of 95°C for 10s, 59°C for 10s, 72°C for 20s, with fluorescence acquisition at the end of each cycle, then a melting curve analysis after the final one. The cycle threshold (Ct) values were determined and background fluorescence was subtracted. Gene expression levels of target genes were calculated, relative to the internal reference gene Actin5C or RS17 for Ae. aegypti and RS7R for An. gambiae. Primers were designed using Vectorbase (www.vectorbase.org) mosquito gene sequences/orthology criteria, and the wMel genome sequence [39], since wMel and wMelPop are closely related [40]. Primer pairs used to detect target gene transcripts are listed in Table 1.

Table 1. Oligonucleotide primers used in quantitative PCR experiments and dsRNA synthesis.

Gene Name Accession no. Forward Primer Reverse Primer
An. gambiae
CEC1 AGAP000693 CCAGAGACCAACCAACCACCAA GCACTGCCAGCACGACAAAGA
DEF1 AGAP011294 CATGCCGCGCTGGAGAACTA GATAGCGGCGAGCGATACAGTGA
LRIM1 AGAP006348 CATCCGCGATTGGGATATGT CTTCTTGAGCCGTGCATTTTC
TEP1 AGAP010815 CGCCCAGGAGCGTACGTTGG CCTGGCGAACAGACCCAAGCTG
CTL4 AGAP005335 ATCGGAATGTCGATCGCTAC CTGTCCGGCGATCAAACTAT
CLIPB3 AGAP003249 CAGATTGTCGTCCACACTGG GCTCAGGGGCAGACAGATAG
RS7R AGAP010592 AGAACCAGCAGACCACCATC GCTGCAAACTTCGGCTATTC
dsRNA-Tep1 [17] AGAP010815 TAATACGACTCACTATAGGGTTTGTGGGCCTTAAAGCGCTG TAATACGACTCACTATAGGGACCACGTAACCGCTCGGTAAG
Ae. aegypti
PGRPS1 AAEL009474 TGGAGCGACATTGGTTACAA GCGATGCCAATCGACTTACT
CECD AAEL000598 GCTAGGTCAAACCGAAGCAG TCCTACAACAACCGGGAGAG
CLIPB37 AAEL005093 TTGGGGGAAAACAGAAACAG GATCTGCTTCCCAGAGAACG
Galactose-specific CTL AAEL005641 GTCTCCGGGTGCAATACACT CCCTATCGTTCCACTTCCAA
Actin5C AAEL011197 ATCGTACGAACTTCCCGATG ACAGATCCTTTCGGATGTCG
RpS17 AAEL004175 CAGGTCCGTGGTATCTCCAT CAGGACATCATCGAAGTCGA
Rel2 [43] AAEL007624 GGACGAGGCAGCGGCGCAGTTTGAGC TCCAGAGGGCCGAGATAAGTTCC
dsRNA-Rel2 [43] AAEL007624 TAATACGACTCACTATAGGGACCGGTGGAAGTGCTC TAATACGACTCACTATAGGGCCCCGATCTCCGTTAT
Wolbachia wMel
ftsZ WD_0723 TGATGCTGCAGCCAATAGAG TCAATGCCAGTTGCAAGAAC
E. coli
dsRNA-LacZ EG10527 TAATACGACTCACTATAGGGAGAATCCGACGGGTTGTTACT TAATACGACTCACTATAGGGCACCACGCTCATCGATAATTT
Open in a new tab

Previously published oligonucleotides are indicated by the reference number following the gene name.

The density of Wolbachia in somatic and stable infections of Ae. aegypti was estimated using both qPCR and qRT-PCR. DNA was extracted using the Livak method and qRT-PCR or qPCR equipment and protocols were the same as those described above. The single copy genes ftsZ (Wolbachia) and Actin5C and S7 (Ae. aegypti) were used to estimate relative numbers of Wolbachia normalized against the mosquito genome.

Plasmodium berghei challenge experiments

General parasite maintenance was carried out as previously described [41]. P. berghei ANKA 2.34 parasites were maintained in 4–10-week-old female Theiler's Original (TO) mice by serial mechanical passage (up to a maximum of eight passages). Hyper-reticulocytosis was induced 2–3 days before infection by treating mice with 200µL i.p. phenylhydrazinium chloride (6mg/ml in PBS; ProLabo UK). Mice were infected by intraperitoneal (i.p.) injection and infections were monitored on Giemsa-stained tail blood smears.

In four independent experiments, individual 4–10 week old Theiler's Original (TO) mice were treated with 200µL i.p. phenylhydraziuium chloride (PH; 6mg/ml in PBS; ProLabo UK) to induce hyper-reticulocytosis. Three days later mice were injected by intraperitoneal (i.p.) injection with 106 parasites of P. berghei ANKA 2.34 as described previously [41]. Three days post mouse infection, batches of 100 starved Anopheles gambiae strain G3 females, eight days post injection with Wolbachia, buffer, E. coli or uninjected controls, were allowed to feed on the infected mice. 24h after feeding, mosquitoes were briefly anesthetized with CO2, and unfeds removed. Mosquitoes were then maintained on fructose [8% (w/v) fructose, 0.05% (w/v) p-aminobenzoic acid] at 19–22°C and 50–80% relative humidity. At day 10 post-feeding, mosquito midguts were dissected, and oocyst numbers (intensity) and prevalence recorded. The Kruskal-Wallis test was used to compare oocyst counts (intensity of infection) and Fisher's exact test for prevalence (percentage of mosquitoes containing at least one oocyst).

Gene knockdown experiments

T7-tailed primers (see Table 1) were used to amplify fragments of the TEP1 and REL2 gene from female cDNA template or the LacZ gene from E. coli total DNA. dsRNA was synthesized using the T7 Megascript kit (Ambion) and adjusted to a concentration of 3 or 4 µg/µl in RNAse free water for dsREL2 and dsTEP1 respectively. For REL2 KD 69nl of dsRNA were injected per female mosquito, For TEP1-wolbachia KD 69 nl of a mix of 2 parts dsRNA to 1 part of purified wMelPop in Schneider's medium (OD 0.3) were injected into the thorax of CO2 anesthetized female An. gambiae mosquitoes (total ∼200 per group). Five days after injection (in order to still fall within the gene knockdown period), mosquitoes were fed on a Plasmodium infected mouse.

Brugia pahangi filarial nematode challenge

Ae. aegypti mosquitoes of the filaria-susceptible Refm strain were fed on sheep blood containing 23 B. pahangi microfilaria per µL eight days post Wolbachia innoculation, plus buffer-injected controls of the same age; any females that did not feed properly were removed. Dissections were carried out 10 days after the infective blood meal under a dissecting stereomicroscope. Kruskal-Wallis tests were used to compare counts of B. pahangi L3 (infective stage larvae).

Acknowledgments

We are grateful to S. O'Neill for provision of the Wolbachia-infected MOS55 cell line, and to E. Devaney for supplying Brugia pahangi microfilariae.

Footnotes

The authors have declared that no competing interests exist.

This study was supported by the Wellcome Trust (http://www.wellcome.ac.uk) grant 079059 and by EU FP7 (http://cordis.europa.eu/fp7) award ‘AnoPopAge’. AMB is supported by EU FP7 award ‘TransMalariaBloc’ and BBSRC (http://www.bbsrc.ac.uk) award number LDAD_P15820. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.

References

  • 1.Hilgenboecker K, Hammerstein P, Schlattmann P, Telschow A, Werren JH. How many species are infected with Wolbachia? - a statistical analysis of current data. FEMS Microbiol Lett. 2008;281:215–220. doi: 10.1111/j.1574-6968.2008.01110.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 2.Sinkins SP. Wolbachia and cytoplasmic incompatibility in mosquitoes. Insect Biochem Mol Biol. 2004;34:723–729. doi: 10.1016/j.ibmb.2004.03.025. [DOI] [PubMed] [Google Scholar]
  • 3.Turelli M, Hoffmann AA. Rapid spread of an inherited incompatibility factor in California Drosophila. Nature. 1991;353:440–2. doi: 10.1038/353440a0. [DOI] [PubMed] [Google Scholar]
  • 4.Turelli M, Hoffmann AA. Cytoplasmic incompatibility in Drosophila simulans: dynamics and parameter estimates from natural populations. Genetics. 1995;140:1319–1338. doi: 10.1093/genetics/140.4.1319. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 5.Hoffmann AA, Turelli M. Cytoplasmic incompatibility in insects. In: O'Neill RV, Hoffmann AA, Werren JH, editors. Influential Passengers. Oxford: Oxford University Press; 1997. pp. 42–80. [Google Scholar]
  • 6.Min KT, Benzer S. Wolbachia, normally a symbiont of Drosophila, can be virulent, causing degeneration and early death. Proc Natl Acad Sci U S A. 1997;94:10792–10796. doi: 10.1073/pnas.94.20.10792. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 7.McMeniman CJ, Lane RV, Cass BN, Fong AW, Sidhu M, et al. Stable introduction of a life-shortening Wolbachia infection into the mosquito Aedes aegypti. Science. 2009;323:141–144. doi: 10.1126/science.1165326. [DOI] [PubMed] [Google Scholar]
  • 8.Brownstein JS, Hett E, O'Neill SL. The potential of virulent Wolbachia to modulate disease transmission by insects. J Invertebr Pathol. 2003;84:24–29. doi: 10.1016/s0022-2011(03)00082-x. [DOI] [PubMed] [Google Scholar]
  • 9.Sinkins SP, O'Neill SL. Wolbachia as a vehicle to modify insect populations. In: Hander AM, James AA, editors. Insect Transgenesis: Methods And Applications. Boca Raton: CRC Press; 2000. pp. 271–287. [Google Scholar]
  • 10.Rasgon JL, Styer LM, Scott TW. Wolbachia-induced mortality as a mechanism to modulate pathogen transmission by vector arthropods. J Med Entomol. 2003;40:125–132. doi: 10.1603/0022-2585-40.2.125. [DOI] [PubMed] [Google Scholar]
  • 11.Cook PE, McMeniman CJ, O'Neill SL. Modifying insect population age structure to control vector-borne disease. Adv Exp Med Biol. 2008;627:126–140. doi: 10.1007/978-0-387-78225-6_11. [DOI] [PubMed] [Google Scholar]
  • 12.Kambris Z, Cook PE, Phuc HK, Sinkins SP. Immune activation by life-shortening Wolbachia and reduced filarial competence in mosquitoes. Science. 2009;326:134–136. doi: 10.1126/science.1177531. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 13.Gwadz RW, Kaslow D, Lee JY, Maloy WL, Zasloff M, et al. Effects of magainins and cecropins on the sporogonic development of malaria parasites in mosquitoes. Infect Immun. 1989;57:2628–2633. doi: 10.1128/iai.57.9.2628-2633.1989. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 14.Kim W, Koo H, Richman AM, Seeley D, Vizioli J, et al. Ectopic expression of a cecropin transgene in the human malaria vector mosquito Anopheles gambiae (Diptera: Culicidae): effects on susceptibility to Plasmodium. J Med Entomol. 2004;41:447–455. doi: 10.1603/0022-2585-41.3.447. [DOI] [PubMed] [Google Scholar]
  • 15.Meister S, Kanzok SM, Zheng XL, Luna C, Li TR, et al. Immune signaling pathways regulating bacterial and malaria parasite infection of the mosquito Anopheles gambiae. Proc Natl Acad Sci U S A. 2005;102:11420–11425. doi: 10.1073/pnas.0504950102. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 16.Frolet C, Thoma M, Blandin S, Hoffmann JA, Levashina EA. Boosting NF-kappaB-dependent basal immunity of Anopheles gambiae aborts development of Plasmodium berghei. Immunity. 2006;25:677–685. doi: 10.1016/j.immuni.2006.08.019. [DOI] [PubMed] [Google Scholar]
  • 17.Garver LS, Dong Y, Dimopoulos G. Caspar controls resistance to Plasmodium falciparum in diverse anopheline species. PLoS Pathog. 2009;5:e1000335. doi: 10.1371/journal.ppat.1000335. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 18.Blandin S, Shiao SH, Moita LF, Janse CJ, Waters AP, et al. Complement-like protein TEP1 is a determinant of vectorial capacity in the malaria vector Anopheles gambiae. Cell. 2004;116:661–670. doi: 10.1016/s0092-8674(04)00173-4. [DOI] [PubMed] [Google Scholar]
  • 19.Blandin SA, Wang-Sattler R, Lamacchia M, Gagneur J, Lycett G, et al. Dissecting the genetic basis of resistance to malaria parasites in Anopheles gambiae. Science. 2009;326:147–150. doi: 10.1126/science.1175241. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 20.Povelones M, Waterhouse RM, Kafatos FC, Christophides GK. Leucine-rich repeat protein complex activates mosquito complement in defense against Plasmodium parasites. Science. 2009;324:258–261. doi: 10.1126/science.1171400. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 21.Moreira LA, Iturbe-Ormaetxe I, Jeffery JA, Lu G, Pyke AT, et al. A Wolbachia symbiont in Aedes aegypti limits infection with dengue, Chikungunya, and Plasmodium. Cell. 2009;139:1268–1278. doi: 10.1016/j.cell.2009.11.042. [DOI] [PubMed] [Google Scholar]
  • 22.McMeniman CJ, Lane AM, Fong AW, Voronin DA, Iturbe-Ormaetxe I, et al. Host adaptation of a Wolbachia strain after long-term serial passage in mosquito cell lines. Appl Environ Microbiol. 2008;74:6963–6969. doi: 10.1128/AEM.01038-08. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 23.Rasgon JL, Gamston CE, Ren X. Survival of Wolbachia pipientis in cell-free medium. Appl Environ Microbiol. 2006;72:6934–6937. doi: 10.1128/AEM.01673-06. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 24.Jin C, Ren X, Rasgon JL. The virulent Wolbachia strain wMelPop efficiently establishes somatic infections in the malaria vector Anopheles gambiae. Appl Environ Microbiol. 2009;75:3373–3376. doi: 10.1128/AEM.00207-09. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 25.Dobson SL, Bourtzis K, Braig HR, Jones BF, Zhou W, et al. Wolbachia infections are distributed throughout insect somatic and germ line tissues. Insect Biochem Mol Biol. 1999;29:153–160. doi: 10.1016/s0965-1748(98)00119-2. [DOI] [PubMed] [Google Scholar]
  • 26.Turelli M. Cytoplasmic incompatibility in populations with overlapping generations. Evolution. 2010;64:232–241. doi: 10.1111/j.1558-5646.2009.00822.x. [DOI] [PubMed] [Google Scholar]
  • 27.Jeffery JAL, Yen NT, Nam VS, Nghia LT, Hoffmann AA, et al. Characterizing the Aedes aegypti population in a Vietnamese village in preparation for a Wolbachia-based mosquito control strategy to eliminate dengue. PloS Negl Trop Dis. 2009;3:e552. doi: 10.1371/journal.pntd.0000552. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 28.Hedges LM, Brownlie JC, O'Neill SL, Johnson KN. Wolbachia and virus protection in insects. Science. 2008;322:702. doi: 10.1126/science.1162418. [DOI] [PubMed] [Google Scholar]
  • 29.Teixeira L, Ferreira A, Ashburner M. The bacterial symbiont Wolbachia induces resistance to RNA viral infections in Drosophila melanogaster. PLoS Biol. 2008;6:e1000002. doi: 10.1371/journal.pbio.1000002. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 30.Osborne SE, Leong YS, O'Neill SL, Johnson KN. Variation in antiviral protection mediated by different Wolbachia strains in Drosophila simulans. PLoS Pathog. 2009;5:e1000656. doi: 10.1371/journal.ppat.1000656. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 31.Brownlie JC, Johnson KN. Symbiont-mediated protection in insect hosts. Trends Microbiol. 2009;17:348–354. doi: 10.1016/j.tim.2009.05.005. [DOI] [PubMed] [Google Scholar]
  • 32.Oliver KM, Russell JA, Moran NA, Hunter MS. Facultative bacterial symbionts in aphids confer resistance to parasitic wasps. Proc Natl Acad Sci U S A. 2003;100:1803–1807. doi: 10.1073/pnas.0335320100. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 33.Scarborough CL, Ferrari J, Godfray HC. Aphid protected from pathogen by endosymbiont. Science. 2005;310:1781. doi: 10.1126/science.1120180. [DOI] [PubMed] [Google Scholar]
  • 34.Blanford S, Chan BH, Jenkins N, Sim D, Turner RJ, et al. Fungal pathogen reduces potential for malaria transmission. Science. 2005;308:1638–1641. doi: 10.1126/science.1108423. [DOI] [PubMed] [Google Scholar]
  • 35.Scholte EJ, Ng'habi K, Kihonda J, Takken W, Paaijmans K, et al. An entomopathogenic fungus for control of adult African malaria mosquitoes. Science. 2005;308:1641–1642. doi: 10.1126/science.1108639. [DOI] [PubMed] [Google Scholar]
  • 36.Bell AS, Blanford S, Jenkins N, Thomas MB, Read AF. Real-time quantitative PCR for analysis of candidate fungal biopesticides against malaria: technique validation and first applications. J Invert Pathol. 2009;100:160–168. doi: 10.1016/j.jip.2009.01.006. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 37.Marhoul Z, Pudney M. A mosquito cell line (MOS55) from Anopheles gambiae larvae. Trans R Soc Trop Med Hyg. 1972;66:183–184. doi: 10.1016/0035-9203(72)90068-5. [DOI] [PubMed] [Google Scholar]
  • 38.Macdonald WW, Sheppard PM. Cross-over values in the sex chromosomes of the mosquito Aedes aegypti and evidence of the presence of inversions. Ann Trop Med Parasitol. 1965;59:74–87. doi: 10.1080/00034983.1965.11686285. [DOI] [PubMed] [Google Scholar]
  • 39.Wu M, Sun LV, Vamathevan J, Riegler M, DeBoy R, et al. Phylogenomics of the reproductive parasite Wolbachia pipientis wMel: A streamlined genome overrun by mobile genetic elements. PLoS Biol. 2004;2:e327. doi: 10.1371/journal.pbio.0020069. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 40.Sun LV, Riegler M, S. L. O'Neill SL. Development of a physical and genetic map of the virulent Wolbachia strain wMelPop. J Bacteriol. 2003;185:7077–7084. doi: 10.1128/JB.185.24.7077-7084.2003. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 41.Sinden RE. Molecular interactions between Plasmodium and its insect vectors. Cell Microbiol. 2002;4:713–724. doi: 10.1046/j.1462-5822.2002.00229.x. [DOI] [PubMed] [Google Scholar]
  • 42.Smith DL, McKenzie FE. Statics and dynamics of malaria infection in Anopheles mosquitoes. Malar J. 2004;3:n13. doi: 10.1186/1475-2875-3-13. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 43.Magalhaes T, Leandro DC, Ayres CF. Knock-down of REL2, but not defensin A, augments Aedes aegypti susceptibility to Bacillus subtilis and Escherichia coli. Acta Trop. 2010;113:167–173. doi: 10.1016/j.actatropica.2009.10.013. [DOI] [PubMed] [Google Scholar]

Articles from PLoS Pathogens are provided here courtesy of PLOS

RESOURCES